MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer

S Casacuberta-Serra, Í González-Larreategui… - … and Targeted Therapy, 2024 - nature.com
RAS and MYC rank amongst the most commonly altered oncogenes in cancer, with RAS
being the most frequently mutated and MYC the most amplified. The cooperative interplay …

[HTML][HTML] Application of luteolin in neoplasms and nonneoplastic diseases

K Rakoczy, J Kaczor, A Sołtyk, N Szymańska… - International journal of …, 2023 - mdpi.com
Researchers are amazed at the multitude of biological effects of 3′, 4′, 5, 7-
tetrahydroxyflavone, more commonly known as luteolin, as it simultaneously has antioxidant …

[HTML][HTML] Base editing screens define the genetic landscape of cancer drug resistance mechanisms

MA Coelho, ME Strauss, A Watterson, S Cooper… - Nature Genetics, 2024 - nature.com
Drug resistance is a principal limitation to the long-term efficacy of cancer therapies. Cancer
genome sequencing can retrospectively delineate the genetic basis of drug resistance, but …

Activity and resistance to KRASG12C inhibitors in non-small cell lung cancer and colorectal cancer

W Ye, X Lu, Y Qiao, WB Ou - Biochimica et Biophysica Acta (BBA)-Reviews …, 2024 - Elsevier
Non-small cell lung cancer (NSCLC) and colorectal cancer (CRC) are associated with a
high mortality rate. Mutations in the V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog …

rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses

J Ye, H Wang, R Medina, S Chakraborty, M Sun… - Journal of Experimental …, 2023 - Springer
Background Autologous tumor cell-based vaccines (ATVs) aim to prevent and treat tumor
metastasis by activating patient-specific tumor antigens to induce immune memory …

IL-1β mediates the induction of immune checkpoint regulators IDO1 and PD-L1 in lung adenocarcinoma cells

AF Nawas, A Solmonson, B Gao… - Cell Communication and …, 2023 - Springer
Introduction Inflammation plays a significant role in various cancers, including lung cancer,
where the inflammatory cytokine IL-1β is often elevated in the tumor microenvironment …

[HTML][HTML] KRAS, a New Target for Precision Medicine in Colorectal Cancer?

A Boilève, C Smolenschi, A Lambert, V Boige… - Cancers, 2024 - mdpi.com
Simple Summary Colorectal cancer (CRC) is a deadly disease in which KRAS mutations are
prevalent and are associated with poor prognosis. The emergence of KRAS inhibitors is a …

Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases

J Lv, X Song, Z Luo, D Huang, L **ao… - Frontiers in …, 2025 - frontiersin.org
Luteolin is a flavonoid widely found in plants, including vegetables, botanical drugs, and
fruits. Owing to its diverse pharmacological activities, such as anticancer, oxidative stress …

Comparative Review on Cancer Pathology from Aberrant Histone Chaperone Activity

J Lee, X Bao - International Journal of Molecular Sciences, 2024 - mdpi.com
Histone chaperones are integral to chromatin dynamics, facilitating the assembly and
disassembly of nucleosomes, thereby playing a crucial role in regulating gene expression …

From Subtypes to Solutions: Integrating CMS Classification with Precision Therapeutics in Colorectal Cancer

X Ding, H Huang, Z Fang, J Jiang - Current Treatment Options in Oncology, 2024 - Springer
The biological heterogeneity of colorectal cancer makes its molecular characteristics
essential for therapeutic decision-making and prognostic evaluation. Recent advancements …